Clinical Trials Logo

Side Effects clinical trials

View clinical trials related to Side Effects.

Filter by:

NCT ID: NCT04699760 Completed - Quality of Life Clinical Trials

The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer

Start date: April 2015
Phase: Phase 4
Study type: Interventional

The aim of this study is to determine the effects of n-3 PUFAs on weight, physical funktion and quality of life in patients with colorectal cancer.

NCT ID: NCT04350398 Completed - Clinical trials for Breast Cancer Female

Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast Cancer

HippoBreastCa
Start date: April 20, 2017
Phase: N/A
Study type: Interventional

Breast cancer is the most common women's cancer and the third leading cause of death. Advances in prevention, detection and primary treatment have improved overall survival leading to its growing acceptance as a long-term disease. Following the announcement of breast cancer, but also after primary treatment, some symptoms appear directly compromising psychic and physical spheres. Hippotherapy is an emerging specialized rehabilitation approach performed through specially trained horses by accredited health professionals. The proposed hippotherapy program offers key elements for physical, psychic and social reinforcement, complementing conventional care. The aim is to provide patients with tools to consolidate their self-awareness and thus strengthen their ability to cope with the disease.

NCT ID: NCT04284020 Recruiting - Prostate Cancer Clinical Trials

Educational Program Plus Physiotherapy After Prostatectomy

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

Objective: to find out the effectiveness of therapeutic education program plus pelvic-perineal physical therapy in radical robotic prostatectomy men in terms of quality of life (QoL), urinary incontinence (UI), erectile dysfunction (ED) and muscle strength. Design: Randomized, controlled and single blinded clinical trial. Participants will be randomly assigned in two groups. Experimental group: training pelvic-perineal physical therapy plus lifestyle education. Control group: training in pelvic-perineal physical therapy only. In the 2 groups several physical therapy measurements will be undertaken: 1st before physical therapy treatment, 2nd, 3 th and 4th after 3, 6 and 12 months after initial measurement. Study subjects: Post radical robotic prostatectomy men, which have not been already treated with adjuvant treatment and pelvic-perineal physical therapy, and after reading, understanding and freely signing an informed consent form. Sample size: 84 subjects will be included (42 subjects per group). To have a statistical power of 90% to detect an average difference of 10 points between two groups in the change of quality of life according to the questionnaire validated in Spanish SF-12, assuming a standard deviation of the change of 20 points based on the study from Hou et al, establishing an alpha risk of 0.05, in a bilateral contrast and assuming a 10% of drops outs. Data analysis: Separate analyzes of each variable collected in the two groups will be carried out. For continuous variables, means, medians, standard deviations and quartiles will be calculated, depending on the assumption or not, respectively, of the assumption of their normality previously determined with the Shapiro Wilk test (S-W). Qualitative variables will be described with absolute and relative percentage frequencies. Effectiveness will be evaluated by comparing between the two groups of the change in outcome variables between measurements.

NCT ID: NCT04215601 Completed - Phototherapy Clinical Trials

Effect of Phototherapy on Serum Calcium

Start date: February 1, 2020
Phase:
Study type: Observational [Patient Registry]

Through this study our aim was to evaluate whether significant change in serum calcium level occurs in term newborns who are undergoing phototherapy and to find out the association between effect of phototherapy on serum calcium level and birth weight, postnatal age and type of feeding.

NCT ID: NCT04204681 Completed - Children, Only Clinical Trials

Tonsillar Retractor-induced Subacute Submassive Tongue Edema

Start date: November 1, 2018
Phase:
Study type: Observational

This study aimed to detect tongue edema induced by the pressure exerted by tonsillar retractor; edema detection was made through tongue area measurement using ultrasonography (USG) in pediatric patients who underwent tonsillectomy surgeries.

NCT ID: NCT02935803 Recruiting - Clinical trials for Urinary Stress Incontinence

A Study on the Anti-incontinent Effectiveness of the mTVM Method in POPQ Stage II-III Patients

TVMvsmTVM
Start date: July 2016
Phase: N/A
Study type: Interventional

An increasing number of specific procedures have been described for the surgical repair of pelvic organ prolapse (POP) and concomitant stress urinary incontinence (SUI). The investigators introduced an alternative operative method for POP-Q II-III repair and anti-incontinence with the trans vaginal mesh (TVM) anterior edge fixed to the periurethral tissues at the level of mid-urethra. The efficacy and short- and long-term complication profile, of this new surgical technique as compared with those of non-modified TVM.

NCT ID: NCT02807610 Completed - Hemodynamics Clinical Trials

Etomidate vs Propofol-Induction Characteristics

Induction
Start date: March 2011
Phase: Phase 4
Study type: Interventional

The ideal induction agent for day care surgery should have properties of rapid, smooth induction, better haemodynamic profile, faster recovery and devoid of side effects in the form of pain on injection, involuntary movements, respiratory depression and post-operative nausea/vomiting. Propofol is the drug being used for day care surgeries because of its rapid, smooth induction and faster recovery. But its use is associated with pain on injection (even with added lidocaine), hypotension and respiratory depression. So the need for an agent with better hemodynamic control and lesser side effects was felt. The introduction of etomidate lipuro revolutionised the anaesthesia practice. It possesses many of the properties of an ideal induction agent. This newer formulation of etomidate in lipid emulsion i.e. etomidate lipuro is known to have rapid, smooth induction, haemodynamic stability and lesser side effects than older etomidate with propylene glycol (hypnomidate). Hence, investigators devised a prospective randomized controlled open trial and compared this newer lipid formulation of etomidate with propofol in terms of - induction time, haemodynamic parameters and side effect profile.

NCT ID: NCT02248350 Completed - Prostate Cancer Clinical Trials

An Exercise Intervention for Prostate Cancer Patients Receiving Androgen Deprivation Therapy

MIGHTY
Start date: September 2014
Phase: N/A
Study type: Interventional

This main purpose of this study is to examine the effects of an exercise intervention to counteract adverse side effects related to Androgen Deprivation Therapy (ADT) in prostate cancer patients. Specifically, a supervised and home-based exercise program will be used to assess its impact on clinical and behavioral variables related to ADT in prostate cancer patients.

NCT ID: NCT02215668 Unknown status - Pain Clinical Trials

The Effect of Physical Exercise in Reducing Pain in Women Undergoing Mammography

Start date: August 2014
Phase: N/A
Study type: Interventional

Mammography is a systematic way in the main programs of screening for breast cancer in women over 40 or 50 years old, according to screening programs, but most research has shown a frequency of discomfort and pain during the examination mammography. This study is a randomized controlled trial, whose intervention will be a sequence of exercises body warming and muscle stretching, performed systematic manner and supervised by a physical educator. It is expected to find in this study a possible impact of physical exercise in reducing pain after mammography examination.

NCT ID: NCT02194023 Completed - Dental Plaque Clinical Trials

Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.

Start date: September 2011
Phase: Phase 2
Study type: Interventional

In the current study we tested the hypothesis that new 0.05% Cetylpyridinium chloride (CPC) mouthrinse formulations containing 0.12% or 0.03% chlorhexidine digluconate (CHX): 1) yield similar or better clinical results regarding the inhibition of de novo plaque growth compared to those achieved with an already marketed 0.12% CHX mouthrinse (Perio-Aid Treatment without alcohol. Dentaid, Spain), 2) reduce the side effects caused by the marketed 0.12% CHX formula and 3) that these mouthrinses have no negative microbiological effects, and they control total bacterial loads.